107 related articles for article (PubMed ID: 37991848)
1. Rapid Induction of Long-Lasting Systemic and Mucosal Immunity via Thermostable Microneedle-Mediated Chitosan Oligosaccharide-Encapsulated DNA Nanoparticles.
Li M; Yang L; Wang C; Cui M; Wen Z; Liao Z; Han Z; Zhao Y; Lang B; Chen H; Qian J; Shu Y; Zeng X; Sun C
ACS Nano; 2023 Dec; 17(23):24200-24217. PubMed ID: 37991848
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
4. Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier.
Saeed MI; Omar AR; Hussein MZ; Elkhidir IM; Sekawi Z
Hum Vaccin Immunother; 2015; 11(10):2414-24. PubMed ID: 26186664
[TBL] [Abstract][Full Text] [Related]
5. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
6. Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19.
Yin Y; Su W; Zhang J; Huang W; Li X; Ma H; Tan M; Song H; Cao G; Yu S; Yu D; Jeong JH; Zhao X; Li H; Nie G; Wang H
ACS Nano; 2021 Sep; 15(9):14347-14359. PubMed ID: 34472328
[TBL] [Abstract][Full Text] [Related]
7. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2.
Nguyen KG; Mantooth SM; Vrabel MR; Zaharoff DA
Front Immunol; 2022; 13():858904. PubMed ID: 35592324
[TBL] [Abstract][Full Text] [Related]
9. Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Ganesan S; Acosta H; Brigolin C; Orange K; Trabbic K; Chen C; Lien CE; Lin YJ; Lin MY; Chuang YS; Fattom A; Bitko V
PLoS One; 2022; 17(11):e0272594. PubMed ID: 36322572
[TBL] [Abstract][Full Text] [Related]
10. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.
Cacciottolo M; Nice JB; Li Y; LeClaire MJ; Twaddle R; Mora CL; Adachi SY; Chin ER; Young M; Angeles J; Elliott K; Sun M
Microbiol Spectr; 2023 Jun; 11(3):e0050323. PubMed ID: 37093009
[TBL] [Abstract][Full Text] [Related]
12. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.
Moon S; Wang Y; Edens C; Gentsch JR; Prausnitz MR; Jiang B
Vaccine; 2013 Jul; 31(34):3396-402. PubMed ID: 23174199
[TBL] [Abstract][Full Text] [Related]
13. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
Kingstad-Bakke B; Lee W; Chandrasekar SS; Gasper DJ; Salas-Quinchucua C; Cleven T; Sullivan JA; Talaat A; Osorio JE; Suresh M
Proc Natl Acad Sci U S A; 2022 May; 119(20):e2118312119. PubMed ID: 35561224
[TBL] [Abstract][Full Text] [Related]
14. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
16. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
17. Sublingual Dissolving Microneedle (SLDMN)-Based Vaccine for Inducing Mucosal Immunity against SARS-CoV-2.
Kim Y; Park IH; Shin J; Choi J; Jeon C; Jeon S; Shin JS; Jung H
Adv Healthc Mater; 2023 Oct; 12(26):e2300889. PubMed ID: 37337388
[TBL] [Abstract][Full Text] [Related]
18. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
Ye T; Yue Y; Fan X; Dong C; Xu W; Xiong S
Vaccine; 2014 Jul; 32(35):4457-4465. PubMed ID: 24958702
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.
Lebre F; Borchard G; Faneca H; Pedroso de Lima MC; Borges O
Mol Pharm; 2016 Feb; 13(2):472-82. PubMed ID: 26651533
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]